Trials / Completed
CompletedNCT02956083
The Effect of Tear Supplements on Contact Lens Comfort
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of the Incarnate Word · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this investigation is to determine if lipid based artificial tear supplementation has an impact on contact lens discomfort (CLD).
Detailed description
Contact lens discomfort (CLD) is the most common cause of discontinuing contact lens wear. Despite years of research and innovations in technology, CLD remains highly prevalent, and thus it is a major concern for patients and practitioners. Studies suggest that meibomian gland dysfunction (MGD) is a cause of CLD. Several lipid-based artificial tears have recently been designed to address dry eye associated with MGD. In this study, the investigators examine if the benefits of lipid based artificial tears extend to improving contact lens comfort. Studies have demonstrated some usefulness of non-lipid based tear supplements in the management of contact lens discomfort. However, the relief was moderate and short-term. To date, no study has examined the impact of lipid based artificial tears on contact lens discomfort. In this study, the investigators will address this gap in knowledge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systane Balance eye drops | Propylene Glycol 0.6% Over the counter lipid based artificial tears. |
| OTHER | Systane Contacts eye drops | Hydroxypropyl methycellulose over the counter non-lipid based artificial tears |
| OTHER | saline | Saline - no brand name |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2016-11-04
- Last updated
- 2016-11-04
Source: ClinicalTrials.gov record NCT02956083. Inclusion in this directory is not an endorsement.